cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician before use if you have high blood pressure or glaucoma (Cornelis and El-Sohemy 2007, Chandrasekaran et al. 2005, Noordzij et al. 2005, Avisar et al. 2002, Arya et al. 2000, Jee et al. 1999, Creighton and Stanton 1990).
caution1 Note: This statement is also required at subtherapeutic quantities for products providing 40 mg or more caffeine per day from all sources for Class II and III applications.
cautionAsk a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant, breastfeeding, or attempting to conceive (Nawrot et al. 2003).
cautionWhen using this product avoid taking other health products, foods or beverages that contain caffeine and/or increase blood pressure (FDA 2023; Bui et al. 2006; Bouchard et al. 2005; Haller et al. 2005; NIH 2004; Berardi et al. 2002; Vahedi et al. 2000; Zimmerman 1992).
contraindicationDo not use if you have high blood pressure or glaucoma (Cornelis and El-Sohemy 2007, Chandrasekaran et al. 2005, Noordzij et al. 2005, Avisar et al. 2002, Arya et al. 2000, Jee et al. 1999, Creighton and Stanton 1990).
adverse_reactionStop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if hypersensitivity/allergy occurs (Infante et al. 2003; Hinrichs et al. 2002).
adverse_reactionStop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms such as chest pain and irregular heartbeat occur (Higgins and Babu 2013).
adverse_reactionStop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if nervousness, anxiety, insomnia, tremor and/or headache occur (IOM 2001, Zhang 2001, Sawynok 1995).
adverse_reactionWhen using this product diuretic effect may occur.
adverse_reaction1 Note: This statement is also required at subtherapeutic quantities for products providing 40 mg or more caffeine per day from all sources for Class II and III applications.
adverse_reactionReferences: Nakazaki et al. 2021; Clewell et al. 2016; Taylor et al. 2016; Kuhman et al. 2015, McGlade et al. 2015, Morasch et al. 2015, Baggott et al. 2013, Cotroneo et al. 2013; EFSA 2013; EMA 2013; Gardner and McGuffin 2013, Neufingerl et al. 2013, Yang et al. 2013, McGlade et al. 2012, Fiebich et al. 2011; AMR 2010; Morgan and Stevens 2010; Okun et al. 2010, Van den Bogaard et al. 2010; ESCOP 2009; Wang et al. 2009; Calabrese et al. 2008; CPS 2008; Li et al. 2008, Cornelis and El-Sohemy 2007; Powers et al. 2007; Bain et al.2006; Bradley 2006; Bui et al. 2006; Mills et al. 2006; Shils et al. 2006; Turner et al. 2006; Bouchard et al. 2005; Chandrasekaran et al. 2005; Haller et al. 2005; Noordzij et al. 2005; Nathan et al. 2004; Bone 2003; Zangara 2003; Avisar et al. 2002; Barnes et al. 2002; Berardi et al. 2002; Thomsen 2002; Brinker 2001; Nathan et al. 2001; Stough et al. 2001; Arya et al. 2000; Pepping 2000; Vahedi et al. 2000; Jee et al. 1999; Sun et al. 1999; Mester et al. 1995; Xu et al. 1995, Bradley 1992; Zimmerman 1992; Creighton and Stanton 1990; Rai et al. 1990; Jefferson 1988.